Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 782.10

+2.7%

1:25 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (446)	6/5/2000 8:38:00 PM
From: Miljenko Zuanic	Read Replies (1) of 3559

freeedgar.com <<Reporting Person presently intends, subject to market conditions, to sell approximately 600,000 shares of Common Stock in open market transactions in the next several months in order to maintain its aggregate ownership interest in the Company at approximately the same level as was in effect prior to the issuance by the Company to the Reporting Person of the 573,630 shares of Common Stock to be issued on August 3, 2000. Any such decision by the Reporting Person as to the sale of such shares will depend on prevailing market conditions, the Reporting Person's view of the prospects of the Company and other factors. Separately, the term of the Collaboration Agreement is 10 years, but either party may terminate the agreement at the fifth anniversary of the Effective Date (as defined in the Collaboration Agreement) with one year's notice. The Reporting Person has made no decision to terminate the Collaboration Agreement and accordingly can give no assurances that it will or will not terminate such agreement.>>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next